Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Lock Hansen

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
Thrombosis and Haemostasis|July 27, 2011
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort studyJonas Bjerring Olesen, Gregory Y H Lip, Jesper Lindhardsen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 25, 2024
Understanding the incidence of atrial fibrillation and stroke in hypertrophic cardiomyopathy patients: insights from Danish nationwide registriesChristopher R Zörner, Anne-Marie Schjerning, Morten Kvistholm Jensen, et al.
BMJ (Clinical Research Ed.)|November 29, 2012
The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort studyChristian Selmer, Jonas Bjerring Olesen, Morten Lock Hansen, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2008
The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million peopleEmil Loldrup Fosbøl, Gunnar H Gislason, Søren Jacobsen, et al.
Heart (British Cardiac Society)|November 3, 2017
Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillationCaroline Sindet-Pedersen, Laila Staerk, Morten Lamberts, et al.
European Heart Journal Open|March 30, 2026
Clinical implications and recurrence rates of first-time catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a nationwide cohort studyChristopher R Zörner, Lise Da Riis-Vestergaard, Anne-Marie Schjerning, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 22, 2024
Temporal trends in mortality, heart failure hospitalization, and stroke in heart failure patients with and without atrial fibrillation: a nationwide study from 1997 to 2018 on 152 059 patientsMarte Austreim, Nina Nouhravesh, Mariam E Malik, et al.
European Heart Journal|April 8, 2011
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide studyTina Ken Schramm, Gunnar Hilmar Gislason, Allan Vaag, et al.
Circulation|July 29, 2009
Location of cardiac arrest in a city center: strategic placement of automated external defibrillators in public locationsFredrik Folke, Freddy Knudsen Lippert, Søren Loumann Nielsen, et al.
Journal of the American College of Cardiology|February 11, 2014
Reply: A persisting dilemma for triple antithrombotic therapy: are we close to finding the correct answer?Morten Lamberts, Gunnar H Gislason, Jonas Bjerring Olesen, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Thrombosis and Haemostasis|July 27, 2011
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort studyJonas Bjerring Olesen, Gregory Y H Lip, Jesper Lindhardsen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 25, 2024
Understanding the incidence of atrial fibrillation and stroke in hypertrophic cardiomyopathy patients: insights from Danish nationwide registriesChristopher R Zörner, Anne-Marie Schjerning, Morten Kvistholm Jensen, et al.
BMJ (Clinical Research Ed.)|November 29, 2012
The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort studyChristian Selmer, Jonas Bjerring Olesen, Morten Lock Hansen, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2008
The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million peopleEmil Loldrup Fosbøl, Gunnar H Gislason, Søren Jacobsen, et al.
Heart (British Cardiac Society)|November 3, 2017
Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillationCaroline Sindet-Pedersen, Laila Staerk, Morten Lamberts, et al.
European Heart Journal Open|March 30, 2026
Clinical implications and recurrence rates of first-time catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a nationwide cohort studyChristopher R Zörner, Lise Da Riis-Vestergaard, Anne-Marie Schjerning, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 22, 2024
Temporal trends in mortality, heart failure hospitalization, and stroke in heart failure patients with and without atrial fibrillation: a nationwide study from 1997 to 2018 on 152 059 patientsMarte Austreim, Nina Nouhravesh, Mariam E Malik, et al.
European Heart Journal|April 8, 2011
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide studyTina Ken Schramm, Gunnar Hilmar Gislason, Allan Vaag, et al.
Circulation|July 29, 2009
Location of cardiac arrest in a city center: strategic placement of automated external defibrillators in public locationsFredrik Folke, Freddy Knudsen Lippert, Søren Loumann Nielsen, et al.
Journal of the American College of Cardiology|February 11, 2014
Reply: A persisting dilemma for triple antithrombotic therapy: are we close to finding the correct answer?Morten Lamberts, Gunnar H Gislason, Jonas Bjerring Olesen, et al.
Pageof 14